Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer now identifies the website as revision v3.8.0 instead of v3.7.2. The study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-10-31T13:58:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and directs visitors to transition updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-24T17:16:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-17T17:00:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-10T17:59:28.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the history, replacing the previous v3.6.6 entry in the list.
    Difference
    0.0%
    Check dated 2026-09-19T19:14:06.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The history panel shows the sequence of past record versions, illustrating how the study entry has been updated over time; no new text changes are captured in the input.
    Difference
    0.0%
    Check dated 2026-09-05T21:47:35.000Z thumbnail image

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.